NEW DEFINITVE MERGER AGREEMENT... CytRx has agreed to acquire Innovive(IVPH) for total consideration of approximately $21.3 million plus the assumption of Innovive's liabilities. The transaction is expected to close in the third quarter of 2008 subject to customary closing conditions including regulatory clearance, approval by stockholders representing a majority of Innovive shares outstanding, and effectiveness of the registration statement that CytRx
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.